A Comparison of Different Units for Blood Glucose (mmol/L and mg/dl) and Hemoglobin A1c (% and mmol/Mol) Results.
NCT ID: NCT07102498
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
350 participants
INTERVENTIONAL
2025-07-24
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
NCT00202033
1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin Ratio as a Potential Biomarker for Islet β-cell Function and Insulin Resistance Among Patients With Type 2 Diabetes Mellitus
NCT04869605
Blood Glucose Testing and You
NCT01453413
Comparison Study of Lay Person Finger Stick Versus Blood Draw
NCT01913145
The Effects of Normobaric Hypoxia on Blood Glucose Levels.
NCT01302782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bgmmol a1cpercent
BG presented in mmol/L and HbA1c presented in percent
BG mmol/L
BG presented in mmol/L (the standard presentation in Canada)
A1c percent
HbA1c presented in percent (the standard presentation in Canada)
bgmmol a1cmmol
BG presented in mmol/L and HbA1c presented in mmol/mol
BG mmol/L
BG presented in mmol/L (the standard presentation in Canada)
A1c mmol/mol
HbA1c presented in mmol/mol
bgmgdl a1cpercent
BG presented in mg/dl and HbA1c presented in percent
BG mg/dl
BG presented in mg/dl
A1c percent
HbA1c presented in percent (the standard presentation in Canada)
bgmgdl a1cmmol
BG presented in mg/dl and HbA1c presented in mmol/mol
BG mg/dl
BG presented in mg/dl
A1c mmol/mol
HbA1c presented in mmol/mol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BG mmol/L
BG presented in mmol/L (the standard presentation in Canada)
BG mg/dl
BG presented in mg/dl
A1c percent
HbA1c presented in percent (the standard presentation in Canada)
A1c mmol/mol
HbA1c presented in mmol/mol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to use the internet
* Able to read and respond to questions in English or French
* Adults 18+ years old living in Canada
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
units
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.